|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 42.00 USD | -2.14% |
|
+0.86% | -15.49% |
| 09-17 | Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger | MT |
| 08-03 | Supernus Pharmaceuticals, Inc. Revises Earnings Guidance for the Full Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | -2.14% | +0.86% | -15.49% | -8.95% | +53.96% | 2.49B |  | | |
- Stock Market
- Stocks
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
